South America Long Read Sequencing Market

Market Introduction

South America includes Argentina, Brazil and Rest of South America. The factors driving the growth of the market include, growing government support, increasing number of genome sequence programs, and increasing prevalence of chronic disease. Brazil is gaining traction in the adoption of genomic research. Initially, Brazil invested US$11 million to begin a genomics program through various project. Currently, it is receiving funding from numerous organizations worldwide. This initiative proved to be very positive for Brazil in that it has fostered a strong genomics influence in the healthcare sector. Brazil is the preferred source of biomass to feed synthetic microbes, although synthetic biology and agricultural biotechnology are way ahead in developing agriculture products. The Brazilian industry is on the edge of releasing the potential of meeting biotechnology and data science that can hold for the sector. Also, the developments in genomics, artificial intelligence, and remote sensing have enormous potential to enhance human, animal, and environmental health and enabling this progress. Surge in prevalence of chronic diseases is the major factor driving the growth of the SAM long read sequencing market.

South America is witnessing a growing number of COVID-19 cases. With the outbreak of second wave COVID-19, there has been an increasing number of cases in the Latin American countries. Currently, the country is rapidly increasing its clinical programs to fight against the novel corona virus. There has been a rising focus on genomic sequencing and tests. For instance, after two days of Latin America's first case of COVID-19, the researchers at Adolfo Lutz Institute (IAL), the University of São Paulo (USP) in Brazil, and the University of Oxford published the complete genome sequence for the SARS-CoV-2 in March-2020. Moreover, In July 2020, Vale Institute of Technology (ITV) and Fiocruz planned to carry out the most extensive genome sequencing study of the new coronavirus (Sars-CoV-2) so far developed in Brazil. Vale invested R$ 2.4 million in the research. Such initiatives will bring significant growth for instrument in long read sequencing market.

Market Overview and Dynamics

The long read sequencing market in SAM is expected to grow from US$ 40.53 million in 2021 to US$ 150.44 million by 2028; it is estimated to grow at a CAGR of 20.6% from 2021 to 2028. Five years ago, genomic sequencing was restricted to the research environment. At present, it is increasingly used in clinical practice, and over the next five years, genomic data from over 60 million patients are expected to be generated within healthcare. Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives drive transformative change under real-life conditions while addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the market growth. Such strategic initiatives are likely to offer the market players growth opportunities to attain a significant position and grow in the long read sequencing market.

Key Market Segments

The SAM long read sequencing market is segmented based on technology, product, application, workflow and end user, and country. Based on technology, the long read sequencing market is sub-segmented into single-molecule real-time sequencing (SMRT), nanopore sequencing, and loop genomics long-read sequencing. The single-molecule real-time sequencing (SMRT) segment dominated the market in 2020 and loop genomics long-read sequencing segment is expected to be the fastest growing during the forecast period. Based on product, the long read sequencing market is categorized into instruments, consumables, and services. The consumables segment dominated the market in 2020 and services segment is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into identification and fine mapping of structural variation, tandem repeat sequencing, pseudogene discrimination, resolving allele phasing, reproductive genomics, cancer, viral and microbial sequencing. The identification and fine mapping of structural variation segment dominated the market in 2020 and cancer segment is expected to be the fastest growing during the forecast period. Based on workflow, the market is segmented pre-sequencing, sequencing, and data analysis. The sequencing segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on end user, the long read sequencing market is sub-segmented into academic research institutes, hospitals and clinics, and pharma and biotechnology companies. The academic research institutes, hospitals and clinics segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the long read sequencing market in SAM are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Bionano Genomics; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Oxford Nanopore Technologies; and PerkinElmer, Inc. are among others.

Reasons to buy report

• To understand the SAM long read sequencing market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for SAM long read sequencing market
• Efficiently plan M&A and partnership deals in SAM long read sequencing market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form SAM long read sequencing market
• Obtain market revenue forecast for market by various segments from 2021-2028 in SAM region.

SAM Long Read Sequencing Market Segmentation

SAM Long Read Sequencing Market -By Technology

• Single-Molecule Real-Time Sequencing (SMRT)
• Nanopore Sequencing
• Loop Genomics Long-Read Sequencing

SAM Long Read Sequencing Market -By Product

• Instruments
• Consumables
• Services

SAM Long Read Sequencing Market -By Application

• Identification and fine mapping of structural variation
• Tandem Repeat Sequencing
• Pseudogene discrimination
• Resolving allele phasing
• Reproductive genomics
• Cancer
• Viral and Microbial Sequencing
• Others

SAM Long Read Sequencing Market -By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

SAM Long Read Sequencing Market -By End User

• Academic Research Institutes
• Hospitals and Clinics
• Pharma and Biotechnology Companies

SAM Long Read Sequencing Market -By Country

• Brazil
• Argentina
• Rest of SAM

SAM Long Read Sequencing Market -Company Profiles

• Bionano Genomics
• F. HOFFMANN-LA ROCHE LTD.
• Illumina, Inc.
• Oxford Nanopore Technologies
• PerkinElmer, Inc.

South America Long Read Sequencing Market Strategic Insights

South America Long Read Sequencing Market Segmentation Analysis

South America Long Read Sequencing Market Report Highlights

South America Long Read Sequencing Report Scope

South America Long Read Sequencing Market Country and Regional Insights